TC BioPharm (Holdings) (TC BioPharm (Holdings)) Additional Paid-In Capital : $54.43 Mil(As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is TC BioPharm (Holdings) Additional Paid-In Capital?

TC BioPharm (Holdings)'s quarterly additional paid-in capital increased from Jun. 2023 ($22.90 Mil) to Dec. 2023 ($52.05 Mil) and increased from Dec. 2023 ($52.05 Mil) to Mar. 2024 ($54.43 Mil).

TC BioPharm (Holdings)'s annual additional paid-in capital increased from Dec. 2021 ($0.00 Mil) to Dec. 2022 ($40.57 Mil) and increased from Dec. 2022 ($40.57 Mil) to Dec. 2023 ($52.05 Mil).

TC BioPharm (Holdings) Additional Paid-In Capital Historical Data

The historical data trend for TC BioPharm (Holdings)'s Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TC BioPharm (Holdings) Additional Paid-In Capital Chart

TC BioPharm (Holdings) Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Additional Paid-In Capital

14.54

40.57

52.05

TC BioPharm (Holdings) Quarterly Data
	Dec19	Sep20	Dec20	Jun21	Sep21	Dec21	Jun22	Dec22	Mar23	Jun23	Dec23	Mar24
Additional Paid-In Capital	Get a 7-Day Free Trial							40.57	-	22.90	52.05	54.43

TC BioPharm (Holdings) Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

TC BioPharm (Holdings) Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of TC BioPharm (Holdings)'s Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

TC BioPharm (Holdings) (TC BioPharm (Holdings)) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » TC BioPharm (Holdings) PLC (NAS:TCBP) » Definitions » Additional Paid-In Capital

Comparable Companies

Traded in Other Exchanges

T0U:Germany

Address

Maxim 1, 2 Parklands Way, Holytown, Motherwell, Scotland, GBR, ML1 4WR

Website

https://www.tcbiopharm.com

TC BioPharm (Holdings) PLC is a clinical-stage biopharmaceutical company focused on developing novel immunotherapy products that are based on its proprietary allogeneic gamma delta T (abbreviated as GD-T) cell platform.

Executives

Renaissance Capital Partners Ltd	10 percent owner	42 SHAD THAMES, LONDON X0 SE1 2YD
Diana Elizabeth Randall	10 percent owner	C/O RENAISSANCE CAPITAL PARTNERS LTD, 42 SHAD THAMES, LONDON X0 SE1 2YD
Kenneth Edward Randall	10 percent owner	C/O RENAISSANCE CAPITAL PARTNERS LTD, 42 SHAD THAMES, LONDON X0 SE1 2YD
Mark Edward Randall	10 percent owner	C/O RENAISSANCE CAPITAL PARTNERS LTD, 42 SHAD THAMES, LONDON X0 SE1 2YD